Highly tenured physician-scientist and pharmaceutical executive with nearly 20 years of industry experience. Expertise and track record of leadership in clinical development and medical affairs across a broad range of therapeutic areas including bone, and nephrology and inflammation. Oversight of development programs spanning phases 1b, 2, 3, and 4, with deep experience in regulatory interactions around the world through various stages of clinical development, resulting in multiple BLA and NDA approvals, as well as lifecycle management and external communication strategy for all phases of the product lifecycle. Extensive experience leading large matrixed global product teams and clinical development teams and working successfully in complex global alliances. Over 100 peer-reviewed publications and continued appointment as Associate Professor of Medicine at the University of Heidelberg Medical School in Germany.

Speaker Details